SPL
Click for more information
9.20% 9.5¢ starpharma holdings limited

Ann: VIRALEZE relaunched by LloydsPharmacy in the UK, page-6

  1. antibotter
    12,800 Posts.
    lightbulb Created with Sketch. 1391
    clock Created with Sketch.
    30/06/22
    10:26
    Post #: 62290210
    Just an answer to the question of approval in Australia by TGA and distribution into pharmacies

    This is a mute point

    Starpharma has a webstore..........it can be bought online immediately

    So Viraleze is now being promoted as a broad spectrum anti viral (for the new investors this includes  for use against Covid-19 and influenza A&B)

    Good strategy by company

    Look forward to approval by TGA
    Last edited by antibotter: 30/06/22
    SPL Price at posting: 70.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.5¢ 		Change
0.008(9.20%) 		Mkt cap ! $39.14M
Open High Low Value Volume
9.0¢ 9.5¢ 8.8¢ $334.2K 3.710M

Buyers (Bids)

No. Vol. Price($)
2 50354 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 22908 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.